Sidoti's November Micro-Cap Virtual Conference
Presentation Times and Weblinks Released for Over 35 Presenting Companies Wednesday and Thursday, November 9-10, 2022 NEW YORK, NY / ACCESSWIRE / November 8, 2022 / Sidoti & Company, LLC has released...
Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. It offers PRP, a formulation lead product that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes. The company has a research collaboration with University of Jaén that undertakes the research activities for POP1 joint drug discovery program; and a joint research and drug discovery program with Universities of Jaén and Granada to investigate the changes in genetic and protein expression that occur in cancer cells. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.
| 0.0008 | |
| 0.0008 | |
| - | |
| 0.0008 | |
| 0.0008 | |
| 0.0006-0.09 | |
| 266 K | |
| 0.0035 | |
| 332 M | |
| 0 | |
| -0.0091 | |
| 1.961 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: